Your session is about to expire
← Back to Search
Exercise for Sarcopenia
Study Summary
This trial will test whether aerobic exercise can help improve muscle mass in older adults with sarcopenia.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your body mass index (BMI) is between 18 and 32.5.You have recently participated in exercise training.I cannot exercise due to a physical impairment.I have been diagnosed with diabetes, cancer, lung, or kidney disease.You have low muscle mass for your body size.You do not smoke.
- Group 1: Aerobic exercise training followed by resistance training
- Group 2: Resistance training followed by aerobic exercise training
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria should applicants meet to be considered for enrolment in this experiment?
"To be included in this medical trial, volunteers must possess sarcopenia and aged between 65 to 88. The research team is aiming to recruit up to 40 participants for the study."
What is the scope of participants in this clinical trial?
"Indeed, clinicaltrials.gov notes that this medical experiment is currently looking for participants. It was originally posted on March 15th 2020 and updated as recently as February 28th 2022. 40 individuals are needed between two separate sites to take part in the trial."
Is there any age restriction on applicants for this experiment?
"Subjects aged between 65 and 88 are invited to enrol in this trial."
Are there any current recruitment efforts for this clinical experiment?
"Affirmative. Details available on clinicaltrials.gov allude to the fact that, as of February 28th 2022, this medical trial is still looking for participants with 40 people needed from 2 different locations. The study was initially made public on March 15th 2020."
Share this study with friends
Copy Link
Messenger